Literature DB >> 19880318

Effect of chirality of small molecule organofluorine inhibitors of amyloid self-assembly on inhibitor potency.

Abha Sood1, Mohammed Abid, Samson Hailemichael, Michelle Foster, Béla Török, Marianna Török.   

Abstract

The effect of enantiomeric trifluoromethyl-indolyl-acetic acid ethyl esters on the fibrillogenesis of Alzheimer's amyloid beta (Abeta) peptide is described. These compounds have been previously identified as effective inhibitors of the Abeta self-assembly in their racemic form. Thioflavin-T Fluorescence Spectroscopy and Atomic Force Microscopy were applied to assess the potency of the chiral target compounds. Both enantiomers showed significant inhibition in the in vitro assays. The potency of the enantiomeric inhibitors appeared to be very similar to each other suggesting the lack of the stereospecific binding interactions between these small molecule inhibitors and the Abeta peptide.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19880318      PMCID: PMC2785120          DOI: 10.1016/j.bmcl.2009.10.066

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

1.  Analysis of amyloid-beta assemblies using tapping mode atomic force microscopy under ambient conditions.

Authors:  T T Ding; J D Harper
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

Review 2.  Amyloid fibrillogenesis: themes and variations.

Authors:  J C Rochet; P T Lansbury
Journal:  Curr Opin Struct Biol       Date:  2000-02       Impact factor: 6.809

3.  Change and stabilization of the amyloid-beta(1-40) secondary structure by fluorocompounds.

Authors:  Euridice P Vieira; Horst Hermel; Helmuth Möhwald
Journal:  Biochim Biophys Acta       Date:  2003-01-31

4.  Stereoselective interactions of peptide inhibitors with the beta-amyloid peptide.

Authors:  Robert J Chalifour; Richard W McLaughlin; Louis Lavoie; Céline Morissette; Nadine Tremblay; Marie Boulé; Philippe Sarazin; Dino Stéa; Diane Lacombe; Patrick Tremblay; Francine Gervais
Journal:  J Biol Chem       Date:  2003-07-02       Impact factor: 5.157

5.  Both the D-(+) and L-(-) enantiomers of nicotine inhibit Abeta aggregation and cytotoxicity.

Authors:  Susan A Moore; Thomas N Huckerby; Gillian L Gibson; Nigel J Fullwood; Stuart Turnbull; Brian J Tabner; Omar M A El-Agnaf; David Allsop
Journal:  Biochemistry       Date:  2004-01-27       Impact factor: 3.162

6.  Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1.

Authors:  H Naiki; K Higuchi; M Hosokawa; T Takeda
Journal:  Anal Biochem       Date:  1989-03       Impact factor: 3.365

7.  Thioflavine T interaction with synthetic Alzheimer's disease beta-amyloid peptides: detection of amyloid aggregation in solution.

Authors:  H LeVine
Journal:  Protein Sci       Date:  1993-03       Impact factor: 6.725

8.  Molecular mechanism of thioflavin-T binding to the surface of beta-rich peptide self-assemblies.

Authors:  Matthew Biancalana; Koki Makabe; Akiko Koide; Shohei Koide
Journal:  J Mol Biol       Date:  2008-11-14       Impact factor: 5.469

9.  Diflunisal analogues stabilize the native state of transthyretin. Potent inhibition of amyloidogenesis.

Authors:  Sara L Adamski-Werner; Satheesh K Palaninathan; James C Sacchettini; Jeffery W Kelly
Journal:  J Med Chem       Date:  2004-01-15       Impact factor: 7.446

10.  Amyloidosis of Alzheimer's Abeta peptides: solid-state nuclear magnetic resonance, electron paramagnetic resonance, transmission electron microscopy, scanning transmission electron microscopy and atomic force microscopy studies.

Authors:  Oleg N Antzutkin
Journal:  Magn Reson Chem       Date:  2004-02       Impact factor: 2.447

View more
  8 in total

1.  Disassembly of preformed amyloid beta fibrils by small organofluorine molecules.

Authors:  Abha Sood; Mohammed Abid; Catharine Sauer; Samson Hailemichael; Michelle Foster; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2011-02-25       Impact factor: 2.823

2.  Synthesis and application of β-carbolines as novel multi-functional anti-Alzheimer's disease agents.

Authors:  William Horton; Abha Sood; Swarada Peerannawar; Nandor Kugyela; Aditya Kulkarni; Rekha Tulsan; Chris D Tran; Jessica Soule; Harry LeVine; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2016-11-24       Impact factor: 2.823

3.  Design, synthesis and biological activity of multifunctional α,β-unsaturated carbonyl scaffolds for Alzheimer's disease.

Authors:  Seema Bag; Sanjukta Ghosh; Rekha Tulsan; Abha Sood; Weihong Zhou; Christine Schifone; Michelle Foster; Harry LeVine; Béla Török; Marianna Török
Journal:  Bioorg Med Chem Lett       Date:  2013-03-14       Impact factor: 2.823

4.  Folded Conformation, Cyclic Pentamer, Nano-Structure and PAD4 Binding Mode of YW3-56.

Authors:  Haimei Zhu; Yuji Wang; Yaonan Wang; Shurui Zhao; Ming Zhao; Lin Gui; Wenyun Xu; Xiangyun Amy Chen; Yanming Wang; Shiqi Peng
Journal:  J Phys Chem C Nanomater Interfaces       Date:  2013-05-16       Impact factor: 4.126

5.  Structure-activity relationships of organofluorine inhibitors of β-amyloid self-assembly.

Authors:  Béla Török; Abha Sood; Seema Bag; Aditya Kulkarni; Dmitry Borkin; Elizabeth Lawler; Sujaya Dasgupta; Shainaz Landge; Mohammed Abid; Weihong Zhou; Michelle Foster; Harry LeVine; Marianna Török
Journal:  ChemMedChem       Date:  2012-02-20       Impact factor: 3.466

6.  Diaryl hydrazones as multifunctional inhibitors of amyloid self-assembly.

Authors:  Béla Török; Abha Sood; Seema Bag; Rekha Tulsan; Sanjukta Ghosh; Dmitry Borkin; Arleen R Kennedy; Michelle Melanson; Richard Madden; Weihong Zhou; Harry Levine; Marianna Török
Journal:  Biochemistry       Date:  2013-02-06       Impact factor: 3.162

Review 7.  Fluorinated Molecules and Nanotechnology: Future 'Avengers' against the Alzheimer's Disease?

Authors:  Meghna Dabur; Joana A Loureiro; Maria Carmo Pereira
Journal:  Int J Mol Sci       Date:  2020-04-23       Impact factor: 5.923

8.  Small molecule PZL318: forming fluorescent nanoparticles capable of tracing their interactions with cancer cells and activated platelets, slowing tumor growth and inhibiting thrombosis.

Authors:  Shan Li; Yuji Wang; Feng Wang; Yaonan Wang; Xiaoyi Zhang; Ming Zhao; Qiqi Feng; Jianhui Wu; Shurui Zhao; Wei Wu; Shiqi Peng
Journal:  Int J Nanomedicine       Date:  2015-08-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.